admin

1. Abstract 1.1. Objective: To retrospectively analyze the clinical and imaging manifestations differential points between hepatic sinusoidal obstruction syndrome (SOS) and Budd-Chiari syndrome (BCS). 1.2. Material: The clinical symptoms, laboratory examination and imaging findings of 15 cases of hepatic sinusoidal obstruction syndrome and 33 cases of Budd-Chiari syndrome were statistically analyzed, find the identification points. …

Imaging Findings and Differential Diagnosis of Hepatic Sinusoidal Occlusion Syndrome and Budd-Chiari Syndrome Read More »

1. Abstract 1.1. Background: A capsule is a solid dosage form that delivers a defined dose of an active ingredient. Most capsules are made for oral application by mouth with subsequent swallowing. Capsule materials for the shell are not only of importance for the release of active ingredients, but should also be without any impact …

Effects of Different Capsule Types for Oral Application of Active Substances – Investigations with Organ-Specific Cells Read More »

1. Abstract 1.1. Background: The current COVID-19 pandemic has put all health units in crisis. The easy transmissibility facilitated the fast spread to all countries, and Guatemala was not the exception. By May 2020 almost 229 thousand cases were reported, with 3.2% of case fatality. Among the principal mortality risks factors there are: advance age, …

Liver Injury as Mortality Risk Factor in Sars-Cov-2 Read More »

1. Abstract 1.1. Introduction: A few studies have investigated the occurrence of anti-ribosomal P antibody (Anti-P) in autoimmune hepatitis (AIH), based on the partial overlap of clinical and pathological features ofAIH and systemic lupus erythematosus (SLE), for which anti-P is a diagnostic biomarker. In face of the controversial results obtained, this study aimed to evaluate …

Anti-Ribosomal P (Anti-P) Antibodies in Autoimmune Hepatitis Patients Read More »